Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Nalla Anuraag Reddy, Alex Tom, Harsha Prasada Lashkari

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.

Original languageEnglish
Pages (from-to)49-51
Number of pages3
JournalPediatric Hematology Oncology Journal
Issue number2
Publication statusPublished - 06-2022

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children'. Together they form a unique fingerprint.

Cite this